Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System
Author :
Publisher : National Academies Press
Total Pages : 74
Release :
ISBN-10 : 9780309212212
ISBN-13 : 0309212219
Rating : 4/5 (219 Downloads)

Book Synopsis Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System by : Institute of Medicine

Download or read book Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System written by Institute of Medicine and published by National Academies Press. This book was released on 2011-08-05 with total page 74 pages. Available in PDF, EPUB and Kindle. Book excerpt: Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.


Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System Related Books

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System
Language: en
Pages: 74
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-08-05 - Publisher: National Academies Press

GET EBOOK

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, current
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System
Language: en
Pages: 74
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-07-05 - Publisher: National Academies Press

GET EBOOK

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, current
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System
Language: en
Pages: 74
Authors: Forum on Neuroscience and Nervous System Disorders
Categories:
Type: BOOK - Published: 2011-07-05 - Publisher:

GET EBOOK

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, current
Neuroscience Biomarkers and Biosignatures
Language: en
Pages: 128
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2008-01-08 - Publisher: National Academies Press

GET EBOOK

Biomarkers, or biological markers, are quantitative measurements that offer researchers and clinicians valuable insight into diagnosis, treatment and prognosis
Improving and Accelerating Therapeutic Development for Nervous System Disorders
Language: en
Pages: 107
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2014-02-06 - Publisher: National Academies Press

GET EBOOK

Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervo